China Universal Asset Management Co., Ltd.

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1906594 SHANGHAI, F4

Position in ACRS

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$80,253

+$27,112 QoQ

Shares Held

21,401

+21.2% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

China Universal Asset Management Co., Ltd. holds $172,298,843 across 225 Biotechnology names. ACRS ranks #171 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	43,902	$19,603,999
2	REGN	Regeneron Pharmaceuticals, Inc.	21,361	$16,504,363
3	ALNY	Alnylam Pharmaceuticals, Inc.	27,266	$9,021,501
4	INSM	INSMED Inc	47,015	$7,687,892
5	RPRX	Royalty Pharma plc	130,447	$6,257,542
6	IONS	Ionis Pharmaceuticals Inc	77,315	$5,805,583
7	ARGX	Argenx SE	5,035	$3,676,808
8	MRNA	Moderna, Inc.	70,085	$3,560,318

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$80,253	21,401	+21.2%	Shares	Sole	2026-04-28
2025-12-31	$53,141	17,655	+28.7%	Shares	Sole	2026-01-29
2024-09-30	$15,780	13,722	+63.9%	Shares	Sole	2024-10-25
2024-06-30	$9,209	8,372	-38.6%	Shares	Sole	2024-07-19
2024-03-31	$16,897	13,627	+66.3%	Shares	Sole	2024-05-21
2023-12-31	$8,605	8,196	+351.8%	Shares	Sole	2024-05-22
2023-09-30	$12,425	1,814	+95.9%	Shares	Sole	2024-05-22
2023-06-30	$9,602	926	+2.5%	Shares	Sole	2024-05-22
2023-03-31	$7,305	903	+33.2%	Shares	Sole	2024-05-22
2022-12-31	$10,678	678	+8.7%	Shares	Sole	2024-05-22
2022-09-30	$9,821	624	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.